Navigation Links
Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2010 Earnings
Date:2/7/2011

MORRISTOWN, N.J., Feb. 7, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that the Company intends to release its fourth quarter 2010 financial results on Tuesday, February 15, 2011 prior to the open of the U.S. financial markets.  The Company will also host a conference call and webcast at 8:30 a.m. Eastern Time on February 15, 2011 to discuss its financial results and provide an update on the Company's outlook for 2011.  The dial-in number to access the call is US/Canada (877) 251-7980, International (706) 643-1573.

A taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will remain available through 12:00 midnight Eastern Time on March 1, 2011.  The replay may be accessed by dialing (800) 642-1687 and entering pass code 40449367.  From international locations, the replay may be accessed by dialing (706) 645-9291 and entering the same pass code.  To access the webcast, go to Watson's Investor Relations Web site at http://ir.watson.com.  A replay of the webcast will also be available.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on urology and women's health. Watson has operations in many of the world's established and growing international markets.

For press releases and other company information, visit the Watson Web site at http://www.watson.com

(Logo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO)CONTACTS:Investors:Patty EisenhaurWatson Pharmaceuticals, Inc.(973) 355-8141Media:Charlie MayrWatson Ph
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Watson Confirms Welchol® Oral Suspension Patent Challenge
2. Watson Presents Outlook for Continued Long Term Growth
3. Reportlinker Adds Watson Pharmaceuticals Inc.: PharmaVitae Profile
4. Watson Announces Preliminary Financial Performance for FY 2010
5. Watson to Host Investor Day on January 21 in New York City
6. Watsons Generic Fentora® Receives FDA Approval
7. Watson to Present at the 29th Annual JP Morgan Healthcare Conference
8. Watson Announces Novel Oral Contraceptive Approval
9. Watson and Richter Announce Exclusive License Agreement for Esmya™
10. Watson Confirms Exalgo™ Patent Challenge
11. Watson Announces Pricing of Secondary Offering By Selling Stockholder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013   BioCision ... sample standardization and handling in many areas of ... of new patents by the U.S. Patent Office ... products developed to standardize sample handling to ensure ... results in common laboratory procedures. ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... has recently added DrugPatentWatch to its ... http://www.bharatbook.com/drugpatentwatch-tour.pdf )      (Logo: ... comprehensive information on pharmaceutical, drug patents ... supports the critical business functions of ...
(Date:6/19/2013)... , June 19, 2013 Amerivet Solutions, ... servicing all branches of government from Federal to ... expanded their facilities to include complex metal design ... fabricated some very complex aluminum parts for the ... expand our capabilities to service government contracts," states ...
Breaking Medicine Technology:BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2Drug Patent Watch 2Drug Patent Watch 3Amerivet Solutions Expands to Manufacture Complex Metal Designs 2
(Date:6/19/2013)... 19, 2013 Strict rules for ... 2013, Orriant is launching a new tool to ... compliance with regulations. New HHS regulations will ... incentives if their employer offers outcome-based, health-contingent, compliant ... compliant with these standards for nearly a decade. ...
(Date:6/19/2013)... As Januvia lawsuit ... in courts throughout the U.S., Bernstein Liebhard LLP notes ... held a meeting to discuss the safety of Januvia ... According to a June 12th report from Bloomberg.com, the ... Januvia and similar drugs, following a recent study that ...
(Date:6/19/2013)... (June 19, 2013) In what is believed to ... most common form of hereditary dystonia a movement ... in deep brain stimulation report good success rates and ... the Movement Disorders Program at Cedars-Sinai Medical Center,s Department ... the Division of Neurosurgery at Beth Israel Deaconess Medical ...
(Date:6/19/2013)... reveals significant disparities between minority and white clients ... programs. Moreover, these disparities vary widely from state ... for most states there,s something amiss," says Stephan ... "There are strong racial and ethnic disparities for ... treatment programs successfully, and those disparities are something ...
(Date:6/19/2013)... 19, 2013 The Movement ... neurosurgeons, psychiatrists and urologists with specialists in physical ... works with patients and their family members to ... of life. Patients also have the opportunity to ... research. , “Movement disorders can be relentlessly progressive ...
Breaking Medicine News(10 mins):Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 3Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 3Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2Health News:States vary widely on success rates for minorities in drug treatment programs 2Health News:States vary widely on success rates for minorities in drug treatment programs 3Health News:Abington Memorial Hospital’s Neurosciences Institute Opens Movement Disorders Center 2
... Industries, a,leading manufacturer of specialty vehicles in the United ... production facility in Bluffton,Ohio. Company officials plan to move ... Hutchinson, Kansas by November 9, 2007. "The closure ... was,certainly a difficult decision. Since the purchase of this ...
... Center Suite operates with Gryphon compliance services ... resulting in increased productivity for call centers, ... provider of,intelligent customer interaction solutions, today announced that ... the worldwide leader in,On-Demand Contact Governance solutions. This ...
... of pen-and-paper questionnaires/ , Here is a great ... soon be obsolete! Well, at least for people with ... by doctors. Thanks to the RT3 accelerometer, MS patients ... keeping a journal or completing activity questionnaires. The RT3 ...
... took a weekly dose of risedronate, sold as Actonel, ... take the drug, according to a two-year study from ... week at the 29th annual meeting of the American ... through Wednesday at the Hawaii Convention Center. , Susan ...
... More Than 30 years of Healthcare Management Expertise, ... leader in,Provider Network Management solutions, today announced the ... PacifiCare of California, to its board,of directors. ... of the country,s,largest HMOs is a tremendous asset ...
... In the face of an emerging liver cancer crisis in ... developed a test that could help millions. Due to widespread ... population is at high risk for hepatocellular carcinoma (HCC), a ... treated early. Researchers report on a new blood screening ...
Cached Medicine News:Health News:Company Announces Closure of Bluffton, Ohio Plant 2Health News:Amcat Partners With Gryphon to Provide Comprehensive and Guaranteed Do Not Call (DNC) Compliance Solution for Outbound Contact Activities 2Health News:Amcat Partners With Gryphon to Provide Comprehensive and Guaranteed Do Not Call (DNC) Compliance Solution for Outbound Contact Activities 3Health News:Story tips for journalists 2Health News:Story tips for journalists 3Health News:Weekly dose of osteoporosis drug prevents bone loss after breast cancer treatment 2Health News:Jon R. Wampler Joins Portico Systems' Board of Directors 2Health News:Liver cancer marker could yield blood test for early detection 2Health News:Liver cancer marker could yield blood test for early detection 3Health News:Liver cancer marker could yield blood test for early detection 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: